Phase I, Randomized, Double-Blind, Placebo-Controlled Trial Investigating the Safety, Tolerability, and Pharmacokinetics of BS1801 in Healthy Chinese Adult Subjects
Drug Design, Development and Therapy · 2026-05 · Volume 20 · 1-12
DOI: 10.2147/dddt.s610536 ↗Kurz gefasst
Klinische Studie (Phase I) in der Zeitschrift Drug Design, Development and Therapy, 2026-05. Verfasst von Guiling Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Shulan (Hangzhou) Hospital, Shulan International Medical College, Zhejiang Shuren University, Hangzhou, 310022, People's Republic of China. Hauptthemen laut MEDLINE: Organoselenium Compounds, Thioredoxin-Disulfide Reductase, Antifibrotic Agents. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shulan (Hangzhou) Hospital, Shulan International Medical College, Zhejiang Shuren University, Hangzhou, 310022, People's Republic of China.
- National Human Genetic Resources Center, National Research Institute for Family Planning, Beijing, 100081, People's Republic of China.
- Shanghai Yuanxi Medicine Corp, Shanghai, 201203, People's Republic of China.
ORCID-Profile: Yifan Chen
Zitieren
APA
Chen, G., Sheng, G., Wu, K., Jin, T., Jiang, Q., Guo, T., Chen, Y., Yin, H., Zhang, G., Shen, Z., & Zeng, H. (2026). Phase I, Randomized, Double-Blind, Placebo-Controlled Trial Investigating the Safety, Tolerability, and Pharmacokinetics of BS1801 in Healthy Chinese Adult Subjects. Drug Design, Development and Therapy, Volume 20, 1-12. https://doi.org/10.2147/dddt.s610536
Vancouver
Chen G, Sheng G, Wu K, Jin T, Jiang Q, Guo T, et al. Phase I, Randomized, Double-Blind, Placebo-Controlled Trial Investigating the Safety, Tolerability, and Pharmacokinetics of BS1801 in Healthy Chinese Adult Subjects. Drug Design, Development and Therapy. 2026;Volume 20:1-12. doi:10.2147/dddt.s610536
BibTeX
@article{Chen2026,
author = {Chen, Guiling and Sheng, Guoping and Wu, Kaiqi and Jin, Tinghan and Jiang, Qi and Guo, Tong and Chen, Yifan and Yin, Hanwei and Zhang, Guozhou and Shen, Zhenwei and Zeng, Huihui},
title = {Phase I, Randomized, Double-Blind, Placebo-Controlled Trial Investigating the Safety, Tolerability, and Pharmacokinetics of BS1801 in Healthy Chinese Adult Subjects},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--12},
doi = {10.2147/dddt.s610536}
}
EUVIMED